Department of Genetics, Aziz Sancar Institute for Experimental Medicine, İstanbul University, İstanbul, Turkey.
Department of Cardiology, Ufuk University Medical Faculty, Ankara, Turkey.
Turk Kardiyol Dern Ars. 2022 Jan;50(1):22-33. doi: 10.5543/tkda.2022.17203.
Coronary artery disease (CAD) is an important public health problem worldwide. Therefore, it is important to identify the molecular mechanisms and the candidate gene polymorphisms involved in the development of CAD. In this study, we focused on 2 polymorphisms of the atherosclerosis-related genes, ESR1 and CYP19A1.
Unselected 339 individuals who underwent coronary angiography were divided into 2 groups: those with normal coronary arteries (≤30% stenosis) and those with critical disease (≥50% stenosis). Individuals were genotyped for CYP19A1 rs10046 C/T and ESR1 rs2175898 A/G polymorphisms using hybridization probes in real-time PCR. In addition, Gensini and SYNTAX scores were assessed.
ESR1 polymorphism was significantly associated with CAD in men (p=0.036) via G allele carriage. Multiple logistic regression analyses showed that ESR1 rare allele carriage was associated with CAD presence (Odds ratio=2.12, 95% confidence interval 1.01-4.1, p=0.025), adjusted for age, HDL-C, LDL-C and smoking status in the male group. CYP19A1 rs10046 T allele carriers had a 2.84-fold increased risk for complex CAD in multiple logistic regression analysis (p=0.016). Furthermore, the univariate analysis of variance indicated that T allele carriage of rs10046 polymorphism was associated with increased SYNTAX and Gensini scores (p<0.05). Female patients who were ESR1 G allele carriers with CAD had higher adiponectin levels (p=0.005), whereas HbA1c levels were associated with T allele of CYP19A1 in the CAD group (p=0.004) and male CAD group (p=0.018).
The CYP19A1 and ESR1 polymorphisms were associated with the presence and severity of CAD. These gene polymorphisms warrant further studies for the elucidation of their contribution to CAD development.
冠心病(CAD)是全世界一个重要的公共卫生问题。因此,识别与 CAD 发展相关的分子机制和候选基因多态性非常重要。在这项研究中,我们专注于与动脉粥样硬化相关的基因 ESR1 和 CYP19A1 的 2 个多态性。
我们将 339 名未经选择的接受冠状动脉造影的个体分为 2 组:冠状动脉正常(狭窄程度≤30%)和严重疾病(狭窄程度≥50%)。使用实时 PCR 中的杂交探针对 CYP19A1 rs10046 C/T 和 ESR1 rs2175898 A/G 多态性进行个体基因分型。此外,评估了 Gensini 和 SYNTAX 评分。
ESR1 多态性与男性 CAD 显著相关(p=0.036),通过 G 等位基因携带。多因素逻辑回归分析显示,ESR1 稀有等位基因携带与 CAD 存在相关(比值比=2.12,95%置信区间 1.01-4.1,p=0.025),在男性组中调整年龄、HDL-C、LDL-C 和吸烟状况。在多因素逻辑回归分析中,CYP19A1 rs10046 T 等位基因携带者发生复杂 CAD 的风险增加了 2.84 倍(p=0.016)。此外,单因素方差分析表明,rs10046 多态性 T 等位基因携带与增加的 SYNTAX 和 Gensini 评分相关(p<0.05)。患有 CAD 的 ESR1 G 等位基因携带者的女性患者的脂联素水平更高(p=0.005),而 CAD 组(p=0.004)和男性 CAD 组(p=0.018)中 HbA1c 水平与 CYP19A1 的 T 等位基因相关。
CYP19A1 和 ESR1 多态性与 CAD 的存在和严重程度相关。这些基因多态性需要进一步研究,以阐明它们对 CAD 发展的贡献。